About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Legislative Tracking Tools
Monthly Archives: November 2011
Less is More – e-Advocacy in a New Budget Era
Early this fall, I wrote a blog posting on the growing role of e-advocacy. Notably covered was the growing use of social media not only by members of Congress (virtually all members are using Twitter, YouTube and/or Facebook) as a … Continue reading
Posted in Advocacy, Current Affairs 1 Comment
New Study on U.S. Drug Shortages Calls for Establishment of Early Warning System
For some time now, there have been shortages in the supply of key drugs, many of which have been key treatments for patients undergoing therapy for extremely serious and life-threatening conditions. The FDA has developed a page on its website … Continue reading
Posted in Current Affairs, FDA Policy 1 Comment
Weekly Roundup 11/11/11
Our first snow fall is behind us. The palette of vivid colors that hung on the trees has begun to fade. The clock has fallen backward, meaning many of us are waking up earlier and tiring more quickly. It is … Continue reading
Posted in Weekly Roundup Comments Off on Weekly Roundup 11/11/11